Editing Genetically modified Poliovirus (PVS-RIPO)

From Glioblastoma Treatments
Revision as of 20:18, 5 April 2024 by Lazy (talk | contribs) (Created page with " {{TreatmentInfo |drug_name=Genetically modified Poliovirus (PVS-RIPO) |category=Oncolytic virotherapy |book_text=In 2015, this phase I trial for recurrent glioblastoma at Duke University received a boost in public interest when an episode of the television show 60 minutes was devoted to it. Most exceptionally, the first two patients treated in this study were complete responders. As of March 2015 (when the 60 minutes special aired) these two complete responders were st...")
(diff) ← Older revision | Latest revision (diff) | Newer revision β†’ (diff)
Jump to navigationJump to search
Warning: You are editing an out-of-date revision of this page. If you publish it, any changes made since this revision will be lost.
Warning: You are not logged in. Your IP address will be publicly visible if you make any edits. If you log in or create an account, your edits will be attributed to your username, along with other benefits.
Please note that all contributions to Glioblastoma Treatments may be edited, altered, or removed by other contributors. If you do not want your writing to be edited mercilessly, then do not submit it here.
You are also promising us that you wrote this yourself, or copied it from a public domain or similar free resource (see Glioblastoma Treatments:Copyrights for details). Do not submit copyrighted work without permission!
Cancel Editing help (opens in new window)

Template used on this page: